ARTICLE
1 November 2021

COVID-19 Key EU Developments, Policy & Regulatory Update No. 65

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.
United States Coronavirus (COVID-19)

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

LATEST KEY DEVELOPMENTS

Competition & State Aid

  • European Commission ramps up combat against cartels, including reigniting dawn raids
  • European Commission adopts Work Programme for 2022
  • European Commission approves new and amended Member State measures to support the economy

Trade / Export Controls

  • European Commissioner for Trade attends G7 Trade Ministerial

Medicines and Medical Devices

  • European Commission establishes portfolio of ten COVID-19 therapeutics
  • European Parliament adopts Resolution on EU transparency in the development, purchase and distribution of COVID-19 vaccines
  • European Commission adopts Work Programme for 2022

Cybersecurity, Privacy & Data Protection

  • European Commission adopts Work Programme for 2022

Attachments: COVID19 KEY EU DEVELOPMENTS No 65

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More